from 2018 to 2019, icap was entrusted by the chinese government to manage the guangzhou biomedical industry fund with a scale of 10 billion yuan
management of 10 billion biomedical industry i...
more
china-japan biomedical industrial park (guangzhou) co., ltd., a wholly-owned subsidiary of icap, signed a strategic cooperation agreement with the people’s government of guangzhou municipality
on april 3rd, the signing ceremony of the stra...
more
icap visited the center for ips cell research and application chaired by professor shinya yamanaka, nobel prize laureates of kyoto university and the father of induced multifunctional cells.
on the morning of july 31,icap went to the cen...
more
elsevier, publisher of the world's top medical journals the lancet and cell, visited icap
representatives from relx group and elsevier a...
more
icap and jetro guangzhou has organized the china-japan cross-border e-commerce pharmaceutical industry webinar
china-japan cross-border e-commerce pharmaceut...
more